Yuke Wu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Effects and risks of endocrine disrupting chemicals
Papers in
-
- RNA Research and Splicing 5
- Circular RNAs in diseases 3
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Mingrong Xi (6 shared papers)Chengbin Zheng (6 shared papers)Jinyi Zhang (6 shared papers)Qianqian Gao (2 shared papers)Yaping Song (2 shared papers)Lin Zhang (2 shared papers)Zhu Zhang (2 shared papers)Bowen Yang (3 shared papers)
- Journals
- Advanced Science (3 papers)Journal of Hazardous Materials (2 papers)Organic Chemistry Frontiers (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Analytica Chimica Acta (1 paper)
- Partner nations
- ChinaUnited StatesSouth Africa
In The Last Decade
Yuke Wu
32 papers receiving 331 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 55
- Health, Toxicology and Mutagenesis 30
- Immunology 45
- Pollution 22
- Molecular Biology 116
Countries citing papers authored by Yuke Wu
This map shows the geographic impact of Yuke Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuke Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuke Wu more than expected).
Fields of papers citing papers by Yuke Wu
This network shows the impact of papers produced by Yuke Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuke Wu. The network helps show where Yuke Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuke Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 34 | |
| 2 | 2013 | 32 | |
| 3 | 2023 | 30 | |
| 4 | 2023 | 25 | |
| 5 | 2012 | 23 | |
| 6 | 2022 | 20 | |
| 7 | 2014 | 17 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2024 | 12 | |
| 12 | 2017 | 12 | |
| 13 | 2019 | 12 | |
| 14 | 2024 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2023 | 9 | |
| 17 | Early protective role of MST1 knockdown in response to experimental diabetic nephropathy. | 2016 | 9 |
| 18 | 2022 | 7 | |
| 19 | 2024 | 5 | |
| 20 | 2023 | 4 |
About Yuke Wu
Yuke Wu is a scholar working on Molecular Biology, Reproductive Medicine, Cancer Research, Biomedical Engineering and Oncology, having authored 38 papers that have together received 337 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), Circular RNAs in diseases (3 papers), Analytical chemistry methods development (3 papers), Catalytic Cross-Coupling Reactions (3 papers), MicroRNA in disease regulation (3 papers) and Organoboron and organosilicon chemistry (3 papers). The work is most often cited by research in Cancer Research (55 citations), Health, Toxicology and Mutagenesis (30 citations), Immunology (45 citations), Pollution (22 citations) and Molecular Biology (116 citations). Yuke Wu has collaborated with scholars based in China, United States and South Africa. Frequent co-authors include Mingrong Xi, Chengbin Zheng, Jinyi Zhang, Qianqian Gao, Yaping Song, Lin Zhang, Zhu Zhang, Bowen Yang, Ruiyu Wang and Bin Zhou. Their work appears in journals such as Advanced Science, Journal of Hazardous Materials, Organic Chemistry Frontiers, Frontiers in Cell and Developmental Biology and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.